IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.

By Yong‐jun Liu. Annual Review of Immunology, 2005

1,784 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/2c0c67f41cb124175c3d684a728135b99e04e205

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

Citations in the corpus

Dendritic-cell-based therapeutic cancer vaccines. (2013, background): “Another subset of blood DCs, plasmacytoid DCs, which represent the main source of type I IFN upon viral infection, have also been assessed as the basis for cancer vaccines (Liu, 2005; Tel et al., 2013).”
Plasmacytoid Dendritic Cells: Recent Progress and Open Questions (2011, background): “The first and only review on pDCs in this series was published in 2005 (1), and nearly all key aspects of pDC biology have been recently reviewed elsewhere (2–7).”
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo (2007, background): “We refer the reader to other excellent reviews that have specifically dealt with plasmacytoid DC”
Steady-state and inflammatory dendritic-cell development (2007, background): “One DC-lineage cell that occurs as a pre-cDC in steady state is the pDC, also known as the natural interferon-producing cel”
Translating innate immunity into immunological memory: implications for vaccine development. (2006, positive): “For example, viruses stimulate IFN-a-mediated differentiation of plasmacytoid DCs into Th1-inducing DCs (Liu, 2005), whereas IL-3 induces such DCs to differentiate into Th2-inducing DCs (Rissoan et al., 1999).”
Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors (2010, neutral): “However, as a possible tradeoff mechanism, TLR7- and TLR9-dependent recognition of endogenous nucleic acids is also a feature of autoimmune diseases such as systemic lupus erythematosus (SLE), a disease associated with autoantibodies to nucleosome and ribonucleoproteins, and immune complex depositio”
Type I interferon in systemic lupus erythematosus and other autoimmune diseases. (2006, background): “, 2000): myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) (Liu, 2005).”
Toll-like receptors and innate immunity (2006, background): “pDCs are specialized for producing large amounts of type I IFNs during viral infection [68].”
Interferon signalling network in innate defence (2006, background): “© 2006 The Authors Journal compilation © 2006 Blackwell Publishing Ltd, Cellular Microbiology , 8 , 907–922 (pDCs), was identified, a hallmark function of which is the capacity to produce prodigious amounts of type I IFNs, consisting of IFNα , IFNβ and IFNω , upon viral exposure or the activation of”
Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. (2006, background): “Plasmacytoid DCs are particularly important as virus sentinels and for inducing type I interferon at peripheral sites of infection (Rinaldo and Piazza, 2004; Freigang et al., 2005; Liu, 2005).”
Sleep and immune function (2011, background): “The numbers of pDC, which produce large amounts of IFNα in response to viral challenges and are capable of directly regulating T cell functions [76], were reduced during sleep, whereas cell counts of total pre-myeloid DC (pre-mDC), which are characterised mainly by IL-12 production, did not change a”